Cite
HARVARD Citation
Creyns, B. et al. (n.d.). DOP018 Baseline ILC1 distribution in blood predicts response to ustekinumab in patients with refractory Crohn's disease. Journal of Crohn's and colitis. pp. S041-S042. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Creyns, B. et al. (n.d.). DOP018 Baseline ILC1 distribution in blood predicts response to ustekinumab in patients with refractory Crohn's disease. Journal of Crohn's and colitis. pp. S041-S042. [Online].